Search

Search Constraints

You searched for: Author/Creator Gorni, Ksenija

Search Results

2. 255  SUNFISH part 2: risdiplam in type 2 and type 3 SMA. Issue 6 (27th May 2022)

3. 256  FIREFISH part 2: risdiplam efficacy and safety in type 1 SMA. Issue 6 (27th May 2022)

4. Distribution of weight, stature, and growth status in children and adolescents with spinal muscular atrophy: An observational retrospective study in the United States. Issue 1 (11th May 2022)

5. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. Issue 10119 (3rd February 2018)

6. Natural history of Type 2 and 3 spinal muscular atrophy: 2‐year NatHis‐SMA study. Issue 2 (24th December 2020)

7. Oral SMN2 splicing modifiers in spinal muscular atrophy: Proof-of-mechanism and ongoing clinical studies. (June 2017)

8. Prevalence of congenital muscular dystrophy in Italy: A population study. (3rd March 2015)

10. Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy. Issue 1 (24th November 2020)